Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2010 18:17

RNS Number : 5208F
Skyepharma PLC
13 January 2010
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SkyePharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

Delta adjustment

 X

3. Full name of person(s) subject to the notification obligation:

D.E. Shaw & Co., L.P. D.E. Shaw & Co. (U.K.), Ltd.

4. Full name of shareholder(s) (if different from 3.):

 N/A

5. Date of the transaction and date on which the threshold is crossed or reached:

 January 11, 2010

6. Date on which issuer notified:

 January 13, 2010

7. Threshold(s) that is/are crossed or reached:

 32%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

 

 

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
 
Type of financial instrument
Exercise price
Expiration date
Exercise/ Conversion period
Number of voting rights instrument refers to
% of voting rights
 
Contract for Differences ("CfD") relating to convertible bond due 2024
 
March 4, 2010
 
3,461,725
Nominal
Delta 
 
14.46%
CfD relating to convertible bond due 2025
 
December 3, 2010
 
2,058,916
Nominal
Delta
 
8.60%
CfD relating to convertible bond due 2025
 
June 3, 2010
 
 2,058,916
Nominal
Delta
 
 8.60%

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,579,557

 

31.66%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Each of D.E. Shaw & Co., L.P. ("DESCO LP") and D.E. Shaw & Co. (U.K.), Ltd. ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D.E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO, Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

Stephen Back (Compliance Department)

15. Contact telephone number:

+1 212-478-0000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDXLFFBFFLBBD
Date   Source Headline
24th Mar 20114:40 pmRNSSecond Price Monitoring Extn
24th Mar 20114:35 pmRNSPrice Monitoring Extension
23rd Mar 20117:00 amRNSFinal Results
10th Mar 201112:25 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSDiscontinuation of PULMICORT pMDI production
4th Feb 20115:16 pmRNSDirector/PDMR Shareholding
11th Jan 20112:44 pmRNSDirector/PDMR Shareholding
10th Jan 20114:24 pmRNSChange of Adviser
20th Dec 20104:35 pmRNSPrice Monitoring Extension
9th Dec 20105:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20107:00 amRNSTrading Update
22nd Nov 20103:00 pmRNSResearch Update
8th Nov 20102:55 pmRNSDirector/PDMR Shareholding
21st Oct 20107:00 amRNSInterim Management Statement
21st Oct 20107:00 amRNSInterim Management Statement
12th Oct 20105:53 pmRNSDirector/PDMR Shareholding
4th Oct 20104:40 pmRNSSecond Price Monitoring Extn
4th Oct 20104:35 pmRNSPrice Monitoring Extension
15th Sep 20104:40 pmRNSSecond Price Monitoring Extn
15th Sep 20104:35 pmRNSPrice Monitoring Extension
10th Sep 20103:03 pmRNSDirector/PDMR Shareholding
3rd Sep 20105:24 pmRNSDirector/PDMR Shareholding
20th Aug 20108:16 amRNSRegains US marketing rights to Flutiform
19th Aug 20103:31 pmRNSDirector/PDMR Shareholding
19th Aug 20107:00 amRNSHalf Yearly Report
17th Aug 20107:00 amRNSAppointment of CEO
6th Aug 20102:46 pmRNSDirector/PDMR Shareholding
19th Jul 201010:46 amRNSHolding(s) in Company
16th Jul 201011:29 amRNSDirector/PDMR Shareholding
24th Jun 201011:34 amRNSResearch Update
23rd Jun 20102:47 pmRNSDirector Declaration
15th Jun 20105:15 pmRNSShare Purchase Plan
12th May 201012:06 pmRNSAGM Statement
12th May 20107:00 amRNSInterim Management Statement
11th May 20104:40 pmRNSSecond Price Monitoring Extn
11th May 20104:35 pmRNSPrice Monitoring Extension
11th May 20103:40 pmRNSHolding(s) in Company
7th May 20104:40 pmRNSSecond Price Monitoring Extn
7th May 20104:35 pmRNSPrice Monitoring Extension
5th May 201012:00 pmRNSBoard Change
27th Apr 20103:16 pmRNSAnnual Information Update
14th Apr 20102:27 pmRNSAnnual Report and Accounts
8th Apr 20105:22 pmRNSShare Purchase Plan
25th Mar 20107:00 amRNSFinal Results
1st Mar 201012:46 pmRNSShare Purchase Plan
5th Feb 20102:34 pmRNSFlutiform US NDA update
1st Feb 20105:24 pmRNSShare Purchase Plan
22nd Jan 20101:20 pmRNSHolding(s) in Company
21st Jan 20103:53 pmRNSRegulatory Update
20th Jan 20105:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.